Literature DB >> 2906108

Regional profiles of steady-state levels of cyclic nucleotides, cyclic AMP phosphodiesterase, and guanylate cyclase activities during late stages of unilateral ischemia in gerbil forebrain.

G C Palmer1, B C Christie-Pope, M A Medina, P M Colombo, S J Palmer.   

Abstract

The present study was an extension of earlier work regarding the role of cyclic nucleotides and related enzymes during cerebral ischemia in the gerbil. Following unilateral carotid occlusion, levels of cyclic AMP and cyclic GMP were measured in four rapidly inactivated brain regions at 3, 6, and 24 hr after permanent occlusion and at 2 hr of occlusion plus 1 hr of reflow. An analysis of variance indicated significant minor fluctuations in the steady-state levels of the two cyclic nucleotides within the frontal cortex, the hippocampus, the striatum, and especially the olfactory tubercle with respect to occlusion time (3 and 24 hr) but not when comparing control vs ischemic hemispheres (except at 3 hr). Changes occurred only in animals developing neurological symptoms of ischemia. At 24 hr postocclusion the specific activity of the low-Km form of cyclic AMP phosphodiesterase was elevated especially on the ischemic side when determined in homogenates of the four brain regions. Alternatively, the high-Km form of the enzyme in the presence or absence of Ca2+-calmodulin was unchanged. Guanylate cyclase activity in tissue homogenates was not influenced by the conditions of ischemia until 24 hr had elapsed, an event likewise unique to symptomatic gerbils. The sensitivity of the enzyme to hematin-catalase was decreased in the ischemic hemispheres of the hippocampus, striatum, and olfactory tubercle. In addition, further activation of the hematin-catalase response by NaN3 was depressed in the ischemic side of the hippocampus and striatum. Taken together these and previous studies indicate that fluctuations in the steady-state levels of cyclic nucleotides that occur rather prominently during acute and to a lesser degree during prolonged ischemia are not correlated with associated changes in enzymes responsible for their synthesis and/or degradation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2906108     DOI: 10.1007/BF00999233

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  38 in total

1.  Brain H-3-catecholamine metabolism in experimental cerebral ischemia.

Authors:  M H Lavyne; M A Moskowitz; F Larin; N T Zervas; R J Wurtman
Journal:  Neurology       Date:  1975-05       Impact factor: 9.910

2.  Putative neurotransmitters and cyclic nucleotides in prolonged ischemia of the cerebral cortex.

Authors:  W D Lust; B B Mrsulja; B J Mrsulja; J V Passonneau; I Klatzo
Journal:  Brain Res       Date:  1975-11-14       Impact factor: 3.252

Review 3.  Effects of psychoactive drugs on cyclic nucleotides in the central nervous system.

Authors:  G C Palmer
Journal:  Prog Neurobiol       Date:  1983       Impact factor: 11.685

4.  Metabolic profile of hippocampal regions after bilateral ischemia and recovery.

Authors:  M S Abel; D W McCandless
Journal:  Neurochem Res       Date:  1982-07       Impact factor: 3.996

5.  Synthesis of compounds with properties of leukotrienes C4 and D4 in gerbil brains after ischemia and reperfusion.

Authors:  M A Moskowitz; K J Kiwak; K Hekimian; L Levine
Journal:  Science       Date:  1984-05-25       Impact factor: 47.728

6.  A gerbil model of cerebral ischemia suitable for drug evaluation.

Authors:  D M Jarrott; F R Domer
Journal:  Stroke       Date:  1980 Mar-Apr       Impact factor: 7.914

7.  Biochemical changes during graded brain ischemia in gerbils. Part 2. Regional evaluation of cerebral blood flow and brain metabolites.

Authors:  W Paschen; B M Djuricic; H J Bosma; K A Hossmann
Journal:  J Neurol Sci       Date:  1983-01       Impact factor: 3.181

8.  Classification of ischemic-induced damage to Na+, K+-ATPase in gerbil forebrain. Modification by therapeutic agents.

Authors:  G C Palmer; S J Palmer; B C Christie-Pope; A S Callahan; M D Taylor; L J Eddy
Journal:  Neuropharmacology       Date:  1985-06       Impact factor: 5.250

9.  Thrombin stimulation of guanosine 3',5'-monophosphate formation in murine neuroblastoma cells (clone N1E-115).

Authors:  R M Snider; E Richelson
Journal:  Science       Date:  1983-08-05       Impact factor: 47.728

10.  Lipoxygenase metabolites of arachidonic acid and the development of ischaemic cerebral oedema.

Authors:  R J Dempsey; M W Roy; D E Cowen; M E Maley
Journal:  Neurol Res       Date:  1986-03       Impact factor: 2.448

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.